MASERA, SILVIA
MASERA, SILVIA
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
2014-01-01 Romagnolo A;Masera S;Mattioda A;Superti G;Santorelli FM;Mongini T;Pinessi L;Cavalla P
Cortical pathology in multiple sclerosis: expression of glutamate transporter EAAT2
2006-01-01 Vercellino M; Merola A; Masera S; Plano F; Votta B; Capello E; Mancardi GL; Giordana MT; Mutani R; Cavalla P
Corticla pathology in multiple sclerosis: expression of glutamate transporter EAAT2
2006-01-01 Vercellino M; Merola A; Masera S; Plano F; Votta B; Capello E; Mancardi GL; Giordana M T; Mutani R; Cavalla P
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter
2009-01-01 Marco Vercellino; Silvia Masera; Marcella Lorenzatti; Cecilia Condello; Aristide Merola; Alessandra Mattioda; Antonella Tribolo; Elisabetta Capello; Giovanni Luigi Mancardi; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla
Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis
2022-01-01 Moccia, Marcello; Loperto, Ilaria; Santoni, Laura; Masera, Silvia; Affinito, Giuseppina; Carotenuto, Antonio; Lanzillo, Roberta; Triassi, Maria; Morra, Vincenzo Brescia; Palladino, Raffaele
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation
2007-01-01 M Vercellino; C Condello; B Votta; A Merola; S Masera; C Piacentino; E Capello; GL Mancardi; R Mutani; M T Giordana; P Cavalla
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation
2007-01-01 M Vercellino; C Condello; B Votta; A Merola; S Masera; C Piacentino; E Capello; G L Mancardi; R Mutani; M T Giordana; P Cavalla
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results
2020-01-01 Capra, Ruggero; Morra, Vincenzo Brescia; Mirabella, Massimiliano; Gasperini, Claudio; Scandellari, Cinzia; Totaro, Rocco; De Rossi, Nicola; Masera, Silvia; Zipoli, Valentina; Patti, Francesco; null, null
Neurodegeneration and iron accumulation in deep grey matter nuclei in multiple sclerosis.
2011-01-01 Vercellino M; Trebini C; Romagnolo A; Chiavazza C; Masera S; Mattioda A; Capello E; Mancardi G; Giobbe D; Mutani R; Giordana MT; Cavalla P
Neuronal and synaptic pathology in grey matter demyelinating lesions in multiple sclerosis
2005-01-01 Vercellino M; Cavalla P; Votta B; Plano F; Merola A; Maragò C; Masera S; Giordana M T; Mutani R
Neuronal and synaptic pathology in the demyelinating lesions of grey matter in multiple sclerosis
2005-01-01 M.Vercelllino; F.Plano; B.Votta; C.Marago; S. Masera; A.Merola; R.Mutani; MT.Giordana; P.Cavalla
Neuronal and synaptic pathology in the demyelinating lesions of grey matter in multiple sclerosis
2005-01-01 Vercellino M; Cavalla P; Votta B; Plano F; Maragò C; Masera S; Merola A; Mutani R; Giordana MT
Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod.
2014-01-01 Masera S;Chiavazza C;Mattioda A;Superti G;Beggiato E;Crosasso P;Broganelli P;Pinessi L;Cavalla P
Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis.
2015-01-01 Masera S;Cavalla P;Prosperini L;Mattioda A;Mancinelli C;Superti G;Chiavazza C;Vercellino M;Pinessi L;Pozzilli C
Patterns of diffuse inflammation and axonal injury in multiple sclerosis normal appearing white matter
2006-01-01 Merola A; Vercellino M; Masera S; Plano F; Votta B; Capello E; Mancardi GL; Giordana MT; Mutani R; Cavalla P
Progranulin expression in brain tissue and cerebrospinal fluidlevels in multiple sclerosis
2011-01-01 Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. | 2014 | Romagnolo A;Masera S;Mattioda A;Superti G;Santorelli FM;Mongini T;Pinessi L;Cavalla P | |
Cortical pathology in multiple sclerosis: expression of glutamate transporter EAAT2 | 2006 | Vercellino M; Merola A; Masera S; Plano F; Votta B; Capello E; Mancardi GL; Giordana MT; Mutani R; Cavalla P | |
Corticla pathology in multiple sclerosis: expression of glutamate transporter EAAT2 | 2006 | Vercellino M; Merola A; Masera S; Plano F; Votta B; Capello E; Mancardi GL; Giordana M T; Mutani R; Cavalla P | |
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter | 2009 | Marco Vercellino; Silvia Masera; Marcella Lorenzatti; Cecilia Condello; Aristide Merola; Alessandra Mattioda; Antonella Tribolo; Elisabetta Capello; Giovanni Luigi Mancardi; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla | |
Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis | 2022 | Moccia, Marcello; Loperto, Ilaria; Santoni, Laura; Masera, Silvia; Affinito, Giuseppina; Carotenuto, Antonio; Lanzillo, Roberta; Triassi, Maria; Morra, Vincenzo Brescia; Palladino, Raffaele | |
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation | 2007 | M Vercellino; C Condello; B Votta; A Merola; S Masera; C Piacentino; E Capello; GL Mancardi; R Mutani; M T Giordana; P Cavalla | |
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation | 2007 | M Vercellino; C Condello; B Votta; A Merola; S Masera; C Piacentino; E Capello; G L Mancardi; R Mutani; M T Giordana; P Cavalla | |
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results | 2020 | Capra, Ruggero; Morra, Vincenzo Brescia; Mirabella, Massimiliano; Gasperini, Claudio; Scandellari, Cinzia; Totaro, Rocco; De Rossi, Nicola; Masera, Silvia; Zipoli, Valentina; Patti, Francesco; null, null | |
Neurodegeneration and iron accumulation in deep grey matter nuclei in multiple sclerosis. | 2011 | Vercellino M; Trebini C; Romagnolo A; Chiavazza C; Masera S; Mattioda A; Capello E; Mancardi G; Giobbe D; Mutani R; Giordana MT; Cavalla P | |
Neuronal and synaptic pathology in grey matter demyelinating lesions in multiple sclerosis | 2005 | Vercellino M; Cavalla P; Votta B; Plano F; Merola A; Maragò C; Masera S; Giordana M T; Mutani R | |
Neuronal and synaptic pathology in the demyelinating lesions of grey matter in multiple sclerosis | 2005 | M.Vercelllino; F.Plano; B.Votta; C.Marago; S. Masera; A.Merola; R.Mutani; MT.Giordana; P.Cavalla | |
Neuronal and synaptic pathology in the demyelinating lesions of grey matter in multiple sclerosis | 2005 | Vercellino M; Cavalla P; Votta B; Plano F; Maragò C; Masera S; Merola A; Mutani R; Giordana MT | |
Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod. | 2014 | Masera S;Chiavazza C;Mattioda A;Superti G;Beggiato E;Crosasso P;Broganelli P;Pinessi L;Cavalla P | |
Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis. | 2015 | Masera S;Cavalla P;Prosperini L;Mattioda A;Mancinelli C;Superti G;Chiavazza C;Vercellino M;Pinessi L;Pozzilli C | |
Patterns of diffuse inflammation and axonal injury in multiple sclerosis normal appearing white matter | 2006 | Merola A; Vercellino M; Masera S; Plano F; Votta B; Capello E; Mancardi GL; Giordana MT; Mutani R; Cavalla P | |
Progranulin expression in brain tissue and cerebrospinal fluidlevels in multiple sclerosis | 2011 | Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P |